Eric Benevich Neurocrine Biosciences Inc (NBIX) insider trading activity

Eric Benevich is Chief Commercial Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 40,778 shares of NBIX, which is worth approximately $5.16 Million. The most recent transaction as insider was on Apr 15, 2024, when has been sold 19,818 shares (Common Stock) at a price of $133.36 per share, resulting in proceeds of $2,642,928. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.8K

0% 3M change

11.92% 12M change

Total Value Held $5.16 Million

ERIC BENEVICH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 15 2024	SELL Open market or private sale	$2,642,928 $133.36 p/Share	19,818 Reduced 32.71%	40,778 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	$1,610,608 $81.27 p/Share	19,818 Added 27.08%	53,365 Common Stock
Mar 14 2024	SELL Open market or private sale	$10,453,500 $139.38 p/Share	75,000 Reduced 64.78%	40,778 Common Stock
Mar 14 2024	BUY Exercise of conversion of derivative security	$6,003,000 $80.04 p/Share	75,000 Added 40.48%	110,299 Common Stock
Feb 28 2024	SELL Open market or private sale	$10,101,750 $134.69 p/Share	75,000 Reduced 64.87%	40,616 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	$4,584,750 $61.13 p/Share	75,000 Added 54.56%	62,473 Common Stock
Feb 13 2024	SELL Open market or private sale	$146,044 $133.01 p/Share	1,098 Reduced 2.63%	40,616 Common Stock
Feb 08 2024	SELL Open market or private sale	$131,506 $134.19 p/Share	980 Reduced 2.41%	39,631 Common Stock
Feb 06 2024	SELL Open market or private sale	$181,913 $142.12 p/Share	1,280 Reduced 3.2%	38,751 Common Stock
Jan 31 2024	SELL Open market or private sale	$169,921 $140.78 p/Share	1,207 Reduced 3.11%	37,601 Common Stock
Aug 21 2023	SELL Open market or private sale	$171,840 $107.4 p/Share	1,600 Reduced 4.21%	36,436 Common Stock
Feb 08 2023	SELL Open market or private sale	$102,037 $104.12 p/Share	980 Reduced 2.77%	34,381 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,780,040 $102.36 p/Share	17,390 Reduced 34.17%	33,501 Common Stock
Feb 06 2023	SELL Open market or private sale	$135,206 $105.63 p/Share	1,280 Reduced 6.68%	17,879 Common Stock
Jan 31 2023	SELL Open market or private sale	$132,709 $109.95 p/Share	1,207 Reduced 6.73%	16,729 Common Stock
Jan 06 2023	SELL Open market or private sale	$50,000 $125.0 p/Share	400 Reduced 2.49%	15,643 Common Stock
Jan 06 2023	BUY Exercise of conversion of derivative security	$17,296 $43.24 p/Share	400 Added 2.43%	16,043 Common Stock
Nov 30 2022	SELL Open market or private sale	$6,295,000 $125.9 p/Share	50,000 Reduced 76.17%	15,643 Common Stock
Nov 30 2022	BUY Exercise of conversion of derivative security	$2,017,000 $40.34 p/Share	50,000 Added 58.34%	35,706 Common Stock
Nov 10 2022	SELL Open market or private sale	$12,536 $125.36 p/Share	100 Reduced 0.64%	15,643 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$4,178 $41.78 p/Share	100 Added 0.63%	15,743 Common Stock
Nov 08 2022	SELL Open market or private sale	$3,082,240 $125.33 p/Share	24,593 Reduced 61.12%	15,643 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$1,027,495 $41.78 p/Share	24,593 Added 37.94%	40,236 Common Stock
Nov 03 2022	SELL Open market or private sale	$1,121,179 $125.02 p/Share	8,968 Reduced 36.44%	15,643 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$374,683 $41.78 p/Share	8,968 Added 26.71%	24,611 Common Stock

Eric Benevich

Chief Commercial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account